20918 Federal Register / Vol. 89, No. 59 / Tuesday, March 26, 2024 / Proposed Rules 
further defines the term fair treatment to 
mean that ‘‘no group of people should bear a disproportionate burden of environmental harms and risks, including those resulting from the negative environmental consequences of industrial, governmental, and commercial operations or programs and policies.’’ 
The State did not evaluate 
environmental justice considerations as part of its SIP submittal; the CAA and applicable implementing regulations neither prohibit nor require such an evaluation. The EPA did not perform an EJ analysis and did not consider EJ in this action. Consideration of EJ is not required as part of this action, and there is no information in the record inconsistent with the stated goal of E.O. 12898 of achieving environmental justice for people of color, low-income populations, and Indigenous peoples. 
List of Subjects in 40 CFR Part 52 
Environmental protection, 
Administrative practice and procedure, 
Air pollution control, Incorporation by reference, Intergovernmental relations, Nitrogen oxides, Ozone, Reporting and recordkeeping requirements, and Volatile organic compounds. 
Dated: March 15, 2024. 
Martha Guzman Aceves, 
Regional Administrator, Region IX. 
[FR Doc. 2024–06264 Filed 3–25–24; 8:45 am] 
BILLING CODE 6560–50–P 
ENVIRONMENTAL PROTECTION 
AGENCY 
40 CFR Part 716 
[EPA–HQ–OPPT–2023–0360; FRL–11164– 
01–OCSPP] 
RIN 2070–AL15 
Certain Existing Chemicals; Request 
To Submit Unpublished Health and Safety Data Under the Toxic Substances Control Act (TSCA) 
AGENCY : Environmental Protection 
Agency (EPA). 
ACTION : Proposed rule. 
SUMMARY : The Environmental Protection 
Agency (EPA or the Agency) is proposing to require manufacturers (including importers) of 16 chemical substances to submit copies and lists of certain unpublished health and safety studies to EPA. Health and safety studies sought by this action will help inform EPA’s responsibilities pursuant to TSCA, including prioritization, risk evaluation, and risk management. DATES : Comments must be received on 
or before May 28, 2024. 
ADDRESSES : Submit your comments, 
identified by docket identification (ID) 
number EPA–HQ–OPPT–2023–0360, through https://www.regulations.gov. 
Follow the online instructions for submitting comments. Do not submit electronically any information you consider to be Confidential Business Information (CBI) or other information whose disclosure is restricted by statute. Additional instructions on commenting or visiting the docket, along with more information about dockets generally, is available at https://www.epa.gov/. 
FOR FURTHER INFORMATION CONTACT : 
For technical information contact: 
Lameka Smith, Data Gathering and Analysis Division (7406M), Office of 
Pollution Prevention and Toxics, Environmental Protection Agency, 1200 Pennsylvania Ave. NW, Washington, DC 20460–0001; telephone number: (202) 564–1629; email address: smith.lameka@epa.gov. 
For general information contact: The 
TSCA-Hotline, ABVI-Goodwill, 422 South Clinton Ave., Rochester, NY 14620; telephone number: (202) 554– 1404; email address: TSCA-Hotline@epa.gov. 
SUPPLEMENTARY INFORMATION : 
I. General Information 
A. Does this action apply to me? 
You may be potentially affected by 
this action if you manufacture 
(including import) chemical substances and mixtures. The following list of North American Industrial Classification System (NAICS) codes is not intended to be exhaustive, but rather provides a guide to help readers determine whether this document applies to them. Potentially affected entities may include: 
•Chemical manufacturing (NAICS 
code 325); 
•Petroleum refineries (NAICS code 
324110); and 
•Tire manufacturing (NAICS code 
32621). 
This action may also affect 
manufacturers of substances for commercial purposes that coincidentally produce the substance during the manufacture, processing, use, or disposal of another substance or mixture, including byproducts and impurities. Such byproducts and impurities may, or may not, in themselves have commercial value. They are nonetheless produced for the purpose of obtaining a commercial advantage since they are part of the manufacture of a chemical product for a commercial purpose. B. What action is the Agency taking? 
EPA is proposing to require 
manufacturers of chemical substances 
listed in this document to submit copies and lists of certain unpublished health and safety studies to EPA. This proposed rule is intended to provide EPA with useful information for prioritization, risk evaluations, and risk management under TSCA section 6 regarding the chemical substances discussed below. This action lists the chemical substances and their Chemical Abstracts Service Registry Numbers (CASRNs) that would be added to 40 CFR 716. It also lists proposed specific data reporting requirements. 
C. What is the Agency’s authority for 
taking this action? 
EPA promulgated the Health and 
Safety Data Reporting Rule that is codified at 40 CFR part 716 under TSCA section 8(d) (15 U.S.C. 2607(d)). EPA is proposing this rule under its authority in TSCA section 8(d) to require the submission of health and safety studies, and lists of studies, regarding certain chemical substances. 
D. What are the estimated incremental 
impacts of this action? 
EPA prepared an economic analysis of 
the impacts associated with the proposed addition of the 16 chemical substances to the TSCA section 8(d) Health and Safety Data Reporting rule, titled, ‘‘TSCA Section 8(d): Economic Impact Analysis for Adding 16 Chemicals to the Health and Safety Data Reporting Rule’’ (Ref. 1). This economic analysis is available in the docket and is summarized here. 
EPA estimates that the costs of this 
action will be approximately $301,956 in the first year of reporting, with 3,388 estimated paperwork burden hours. In addition, EPA has determined that, of the 44 small businesses affected by this action, 1 is estimated to incur a maximum annualized cost impact of more than 1% of revenues. Thus, this action is not expected to have a 
significant adverse economic impact on a substantial number of small entities as further discussed in Unit IV.C. 
E. What should I consider as I prepare 
my comments for EPA? 
1. Submitting CBI. Do not submit CBI 
to EPA through https://www.regulations.gov or email. If you wish to include CBI in your comment, please follow the applicable instructions at https://www.epa.gov/dockets/ commenting-epa-dockets#rules and 
clearly mark the part or all of the information that you claim to be CBI. In addition to one complete version of the 
VerDate Sep<11>2014 17:01 Mar 25, 2024 Jkt 262001 PO 00000 Frm 00040 Fmt 4702 Sfmt 4702 E:\FR\FM\26MRP1.SGM 26MRP1ddrumheller on DSK120RN23PROD with PROPOSALS120919 Federal Register / Vol. 89, No. 59 / Tuesday, March 26, 2024 / Proposed Rules 
comment that includes information 
claimed as CBI, a copy of the comment that does not contain the information claimed as CBI must be submitted for inclusion in the public docket. Information so marked will not be disclosed except in accordance with procedures set forth in 40 CFR part 2 and/or 40 CFR part 703, as applicable. 
2. Tips for preparing your comments. 
When preparing and submitting your comments, see the commenting tips at https://www.epa.gov/dockets/ commenting-epa-dockets.html. 
II. Background A. What chemical substances is EPA 
proposing to add? 
EPA is proposing the addition of 16 
chemical substances to amend the list at 40 CFR 716.120. This list contains chemical substances for which the health and safety study data reporting is required. For this proposed rule, the 16 chemical substances will amend the current list and be added at 40 CFR 716.21(a)(11). If any special exemptions are required for a specific chemical substance, it will be identified in the table below under special exemptions. Special exemptions are reporting requirements that are specific to a chemical substance and would include specific language about specific studies and requirements. The chemical substances being added by this proposed rule are listed below: 
•4,4-Methylene bis(2-chloraniline) 
(CASRN 101–14–4); 
•4-tert-octylphenol(4-(1,1,3,3- 
Tetramethylbutyl)-phenol) (CASRN140– 66–9); 
•Acetaldehyde (CASRN75–07–0); 
•Acrylonitrile (CASRN 107–13–1); 
•Benzenamine (CASRN 62–53–3); 
•Benzene (CASRN 71–43–2); 
•Bisphenol A (CASRN 80–05–7); 
•Ethylbenzene (CASRN 100–41–4); 
•Naphthalene (CASRN 91–20–3); 
•Vinyl Chloride (CASRN 75–01–4); 
•Styrene (CASRN 100–42–5); 
•Tribomomethane (Bromoform) 
(CASRN 75–25–2); 
•Triglycidyl isocyanurate; (CASRN 
2451–62–9); 
•Hydrogen fluoride (CARN 7664– 
39–3); 
•N-(1,3-Dimethylbutyl)-N′-phenyl-p- 
phenylenediamine (6PPD) (CASRN 793– 24–8); and 
•2-anilino-5-[(4-methylpentan-2-yl) 
amino]cyclohexa-2,5-diene-1,4-dione (6PPD-quinone) (CASRN 2754428–18– 5). 
B. What are the proposed reporting 
requirements? 
The proposed reporting requirements 
for the 16 chemical substances listed in Unit II.A. include the following, with the specific types of health and safety studies listed in Unit II.D.: 
•Manufacturers who, in the 10 years 
preceding the date a chemical substance is listed, either have proposed to manufacture or have manufactured any of the listed chemical substances must submit to EPA, during the 60-day reporting period specified in 40 CFR 716.65 and according to the reporting schedule set forth at 40 CFR 716.60, would be required to submit a copy of each specified type of health and safety study which is in their possession at the time the chemical substance is listed in 40 CFR part 716. 
•Manufacturers who, either at the 
time of or after the chemical substance is listed in part 716, propose to manufacture or are manufacturing the listed chemical substance would be required to submit to EPA during the 60-day reporting period specified in 40 CFR 716.65 and according to the reporting schedule set forth at 40 CFR 716.60: 
—A copy of each specified type of 
health and safety study which is in 
their possession at the time the chemical substance is listed; 
—A list of the specified types of health 
and safety studies known to them but not in their possession at the time the chemical substance is listed; 
—A list of the specified types of health 
and safety studies that are ongoing at the time the chemical substance is listed and are being conducted by or for them; 
—A list of the specified types of health 
and safety studies that are initiated after the date the chemical substance is listed and will be conducted by or for them; and 
—A copy of each specified type of 
health and safety study that was previously listed as ongoing or subsequently initiated (i.e., listed in 
accordance with reporting requirements in Unit II.D., respectively) and is now complete regardless of completion date. 
The proposed reporting would be 
required 90 days after date the final rule 
is issued from those who manufacture or proposes to manufacture the listed chemical substance from [to be determined 30 days after date of publication of the final rule] to [to be determined as 90 days after date of publication of the final rule] must inform EPA (by submitting a list) of any studies initiated during the period from [to be determined as 30 days after date of publication of the final rule] to [to be determined as 90 days after date of publication of the final rule] within 30 days of their initiation, but in no case 
later than [to be determined as 120 days after date of publication of the final rule]. 
The proposed reporting described in 
Unit II.D. would be required 90 days after the final rule is issued from those who manufactures or proposes to manufacture the listed chemical substance from [to be determined as 30 days after date of publication of the final rule] to [to be determined as 90 
days after date of publication of the 
final rule] must inform EPA (by submitting a list) of any studies initiated during the period from [to be determined as 30 days after date of publication of the final rule] to [to be determined as 90 days after date of publication of the final rule] within 30 days of their initiation, but in no case later than [to be determined as 120 days after date of publication of the final rule]. 
In addition, if any such person has 
submitted lists of studies that were ongoing or initiated during the period from [to be determined as 30 days after date of publication of the final rule] to [to be determined as 90 days after date of publication of the final rule] to EPA, such person must submit a copy of each study within 30 days after its completion, regardless of the study’s completion date. See 40 CFR 716.60 and 716.65. 
C. What are the exemptions under this 
proposed rule? 
Detailed guidance for reporting 
unpublished health and safety data is provided at 40 CFR part 716. Also found at 40 CFR 716.20 are explanations of reporting exemptions. EPA is proposing that the exemption listed at 40 CFR 716.20(a)(9), for persons manufacturing a substance only as an impurity, would not be available for the substances subject to this proposed rule. An impurity is defined as a chemical 
substance that is unintentionally present with another chemical substance. Impurities are not manufactured for distribution in commerce as chemical substances and have no commercial purpose separate from the chemical substance or mixture of which they are a part. Rulemaking proceedings that add chemical substances and mixtures to 40 CFR 716.120 will specify the types of health and safety studies that must be reported and will specify chemical grade/purity that must be met or exceeded in individual studies. Pursuant to the rulemaking procedure that requires EPA to identify the chemical/grade purity, EPA is requiring reporting on any purity level of the chemical. 
VerDate Sep<11>2014 17:01 Mar 25, 2024 Jkt 262001 PO 00000 Frm 00041 Fmt 4702 Sfmt 4702 E:\FR\FM\26MRP1.SGM 26MRP1ddrumheller on DSK120RN23PROD with PROPOSALS120920 Federal Register / Vol. 89, No. 59 / Tuesday, March 26, 2024 / Proposed Rules 
EPA is proposing to require 
submissions of health and safety studies 
from companies manufacturing the identified chemical substances, including when a company is importing the chemical substance as a pure substance, mixture, formulated product, or article contains the subject chemical substance. Reporting would be required where the chemical substance is included as an impurity. EPA considers conditions of use associated with circumstances where a chemical substance subject to a risk evaluation even where the chemical substance is an impurity. To such ends, health and safety information associated with the conditions of use, whether as a pure chemical, part of a mixture or article, or as an impurity helps inform such risk evaluation. Accordingly, the chemicals included in today’s action are of particular interest to EPA because they are either in the process of prioritization as candidates for high-priority designation or are expected to be candidates in the upcoming years. For those found to be of high priority, EPA is required to immediately conduct a risk evaluation. Collecting health and safety studies on the chemicals identified by this proposal will assist EPA in selecting chemicals to designate as high-priority chemicals as well as conduct risk evaluation on such designated chemicals. 
D. What types of studies must be 
submitted? 
Pursuant to 40 CFR 716.10 and 
716.50, manufacturers are required to 
submit the following types of information: 
•Lists and copies of unpublished 
health and safety studies for all substances specified in this rule on health effects, such as toxicity studies (e.g., in vivo, in vitro) on 
carcinogenicity, reproductive and developmental effects, genotoxicity, neurotoxicity, immunotoxicity, endocrine effects, and other systemic toxicity and toxicokinetic (absorption, distribution, metabolism, or elimination), including modeling studies, in humans or animals. 
•All unpublished studies on 
environmental effects and physical- chemical properties if performed as described in 40 CFR 716.50. 
•All unpublished studies on 
occupational, general population, consumer, and environmental exposure, such as: unpublished studies on inhalation and dermal exposure, human biomonitoring, environmental monitoring of indoor and outdoor air, soil, water, and household dust, chamber emission rates from products or polymeric matrices, and unpublished 
modeling studies that estimate environmental concentrations or human exposures. 
•Studies showing any measurable 
content of the tested substance (single substance or mixture). The composition and purity of test substances must be reported if included as part of the study. 
•Studies previously submitted to 
EPA pursuant to a requirement under TSCA or of the submitter’s own accord and studies conducted or to be conducted pursuant to a TSCA section 4 action are exempt from the submission of lists of health and safety studies required under 40 CFR 716.35 and the submission of studies required under this rule. 
•Surveys, tests, and studies of 
biological, photochemical, and chemical degradation. Chemical identities are part of the submitted health and safety studies or data and must be submitted to EPA. Information from health and safety studies and/or data is not protected from disclosure, except to the extent such studies or information reveal information ‘‘that discloses processes used in the manufacturing or processing of a chemical substance. Or, in the case of a mixture, the portion of the mixture comprised by any of the chemical substances in the mixture,’’ 15 U.S.C. 2613(2)(B). Additional information, listed in the rule’s definition of health and safety study, are not part of a health and safety study (e.g., names of laboratory personnel). 
Submitters asserting a CBI claim for 
information are required to submit a sanitized copy, removing only the information that is claimed as CBI. 
E. How to report? 
All submitters would be required to 
report TSCA section 8(d) data 
electronically, using the CSPP: Submissions for Chemical Safety and Pesticide Programs software (CSPP Software) accessible via EPA’s Central Data Exchange (CDX) system available at https://cdx.epa.gov/. The CSPP 
Software provides a TSCA 8(d) Health and Safety Data Reporting application that a registered CDX user will access to submit TSCA section 8(d) records. Information on how to submit TSCA section 8(d) data is available in the docket (EPA–HQ–OPPT–2023–0360) and via EPA’s TSCA section 8(d) web page for this action at https://www.epa.gov/assessing-and-managing- chemicals-under-tsca/section-8d-health- safety-data-reporting-user-guide-0. Submitters may also contact EPA’s TSCA Hotline at tsca-hotline@epa.gov or 202–554–1404. For help with accessing your CDX account, please contact the CDX help desk at https://
cdx.epa.gov/contact or (888) 890–1995 
(for international callers: (970) 494– 5500). 
1. Submitting confidential business 
information. Any person submitting copies of records may assert a business confidentiality claim covering all or part of the submitted information in accordance with the procedures described in 40 CFR part 703 (88 FR 37155, June 7, 2023 (FRL–8223–02– OCSPP)). Requirements for asserting and maintaining confidentiality claims are described in 40 CFR 703.5. Such claim must be made concurrent with submission of the information. If no such claim accompanies the submission, EPA will not recognize a confidentiality claim, and the information in that submission may be made available to the public without further notice. Confidentiality claims must be substantiated at the time of submission to EPA pursuant to the requirements of 40 CFR 703.5(b). To assert a claim of confidentiality for information contained in a submitted record, the respondent must submit two copies of the document. One copy must be complete. In that copy, the respondent must indicate what information, if any, is claimed as confidential by marking the specific information on each page with a label such as ‘‘confidential’’, ‘‘proprietary’’, 
or ‘‘CBI.’’ The other copy must be a 
public version of the submission and attachments, with all information that is claimed as confidential removed (40 CFR 703.5(c)). Both the copy containing information claimed as CBI and the ‘‘sanitized’’ copy must be submitted 
electronically. The TSCA section 8(d) Health and Safety Data Reporting application incorporates many of the requirements for asserting CBI claims, including substantiation questions, a required certification statement, and prompts to provide a sanitized copy. Further details regarding the requirements for confidentiality claims can be found in 40 CFR part 703. 
2. Submitting harmonized templates. 
Additionally, EPA finalized the requirement for submitting all existing information concerning health and environmental effects in the format of Organization of Economic Cooperation and Development’s (OECD) harmonized templates, where such templates exist for the type of data (codified at 40 CFR 705.15(f)). OECD templates are accessible to the public online at https://oecd.org/ehs/templates/ harmonised-templates.htm. This can be 
accomplished by using the freely 
available IUCLID6 software by exporting the dossier in the OECD Harmonized 
VerDate Sep<11>2014 17:01 Mar 25, 2024 Jkt 262001 PO 00000 Frm 00042 Fmt 4702 Sfmt 4702 E:\FR\FM\26MRP1.SGM 26MRP1ddrumheller on DSK120RN23PROD with PROPOSALS120921 Federal Register / Vol. 89, No. 59 / Tuesday, March 26, 2024 / Proposed Rules 
Template working context. EPA can 
accept any dossiers generated using any version of IUCLID6 available at https:// 
www.epa.gov/tsca-cbi/final-rule- 
requirements-confidential-business- information-claims-under- tsca#Implementation. EPA believes that 
some of the data will already be available as an OECD template if the company had already submitted the studies under the European Union’s Registration, Evaluation, Authorization and Restriction of Chemicals (REACH) 
regulation. In addition to the required template format, those subject to this rulemaking must submit any associated full study reports or underlying data as support documents. The full study reports and support documents are necessary for EPA to understand the full context and evaluate the quality of the data, which is necessary for the Agency to review to determine whether such data may be used for any future Agency actions. If an OECD-harmonized template is not available for a particular endpoint for which the manufacturer has relevant information, then the manufacturer must still submit the data. Such information may include, but is not limited to, raw monitoring data (regardless of having been aggregated or analyzed) of human or environmental exposure assessments and toxicity tests for either human health effects or ecological other environmental effects. 
F. What is the rationale for adding the 
16 chemical substances? 
EPA assessment of chemical 
substances under TSCA section 6 involves a three-stage process: (1) prioritization, (2) risk evaluation, and, as applicable, (3) risk management. Prioritization and risk evaluation are carried out in accordance with procedural regulations at 40 CFR part 702, subparts A and B, respectively. 
During prioritization, EPA identifies 
chemical substances that are candidates for prioritization and then uses reasonably available information to screen each candidate chemical substance against certain criteria and considerations specified in TSCA section 6(b)(1)(A): 
•The hazard and exposure potential 
of the chemical substance; 
•Persistence and bioaccumulation of 
the chemical substance; 
•Potentially exposed or susceptible 
subpopulations; 
•Storage near significant sources of 
drinking water; 
•The conditions of use or significant 
changes in the conditions of use of the chemical substance (Conditions of use is defined under TSCA section 3(4) to mean ‘‘the circumstances, as determined by the Administrator, under which a 
chemical substance is intended, known, or reasonably foreseen to be manufactured, processed, distributed in commerce, used or disposed of.’’); 
•The volume or significant changes 
in the volume of the chemical substance manufactured or processed; and 
•Other risk-based criteria that EPA 
determines to be relevant to the designation of the chemical substance’s priority. 
EPA identified 15 chemical 
substances that are the subject of this proposal as potential candidates for prioritization based on a screening process that is based on a combination of hazard, exposure (including uses), and persistence and bioaccumulation characteristics. To support the prioritization process as well as to inform its risk evaluation findings on any of these substances that EPA might designate as a high-priority substance, EPA is seeking unpublished health and safety studies on these chemical substances to ensure that such studies are available to EPA to inform any activities undertaken pursuant to TSCA section 6. EPA is also including the 6PPD transformation product, 2-anilino- 5-[(4-methylpentan-2-yl) amino]cyclohexa-2,5-diene-1,4-dione (6PPD-quinone) (CASRN: 2754428–18– 5) due to a response to a recent citizen’s petition filed under TSCA section 21 received on 6PPD and 6PPD-quinone. Cited in the petition are the potential impacts of 6PPD-quinone to aquatic organisms and on population levels for some fish, such as the coho salmon. The Agency is including this chemical in this proposed request for unpublished health and safety studies to address data 
needs and to better understand and characterize risks associated with this chemical. For details on 6PPD and 6PPD-quinone and EPA’s current key actions to address this chemical, please visit, https://www.epa.gov/chemical- 
research/6ppd-quinone. 
Information received pursuant to the 
final rule will help inform other EPA activities involving such chemical substances. Additionally, non-CBI information collected pursuant to the final rule would be made public via ChemView. 
Estimated benefits of the final rule 
include addressing market failure stemming from incomplete or imperfect information regarding the hazards associated with the listed chemicals. This final rule addresses market failure by making information about the health and safety effects of the listed chemicals available to EPA. By making this information available, EPA will be able to base decisions on actual data rather than relying on assumptions. Additionally, the information provided by this rule can aid in addressing negative externalities that occur when the costs associated with known hazards are external to manufacturers’ decision- making and may result in overuse and/ or overproduction of certain harmful products. 
III. References 
The following is a listing of the 
documents that are specifically 
referenced in this document. The docket includes these documents and other information considered by EPA. For more information about these references, please consult the technical person listed under 
FOR FURTHER  
INFORMATION CONTACT . 
1. EPA. TSCA Section 8(d): Economic Impact 
Analysis for the Addition of Sixteen 
Chemicals to the Health and Reporting Data Rule (March 2024). 
IV. Statutory and Executive Order 
Reviews 
Additional information about these 
statutes and Executive Orders can be found at https://www.epa.gov/laws- regulations/laws-and-executive-orders. 
A. Executive Order 12866: Regulatory 
Planning and Review and Executive Order 14094: Modernizing Regulatory Review 
This action is not a significant 
regulatory action under Executive Order 12866 (58 FR 51735, October 4, 1993), as amended by Executive Order 14094 (88 FR 21879, April 11, 2023), and was therefore not subject to Executive Order 12866 review. 
B. Paperwork Reduction Act (PRA) 
This action does not impose any new 
information collection burden under the 
PRA, 44 U.S.C. 3501 et seq. OMB has previously approved the information collection activities contained in the existing regulations and has assigned OMB control number 2070–0224 (EPA ICR No. 2703.01). This action requires the reporting of health and safety data to EPA by manufacturers of certain chemical substances to be added to the Health and Safety Data Reporting Rule. EPA intends to use information collected under the rule to assist in chemical assessments under TSCA, and to inform any additional work necessary under environmental protection mandates beyond TSCA. Submitters may designate information as confidential, trade secret, or proprietary. EPA has implemented procedures to protect any confidential, trade secret or proprietary information from disclosure. These procedures comply with TSCA 
VerDate Sep<11>2014 17:01 Mar 25, 2024 Jkt 262001 PO 00000 Frm 00043 Fmt 4702 Sfmt 4702 E:\FR\FM\26MRP1.SGM 26MRP1ddrumheller on DSK120RN23PROD with PROPOSALS120922 Federal Register / Vol. 89, No. 59 / Tuesday, March 26, 2024 / Proposed Rules 
section 14 and EPA’s confidentiality 
regulation, 40 CFR part 2, subpart B. This action requires the reporting of health and safety data to EPA by manufacturers of certain chemical 
substances to be added to the Health and Safety Data Reporting Rule. EPA intends to use information collected under the rule to assist in chemical assessments under TSCA, and to inform any additional work necessary under environmental protection mandates beyond TSCA. Submitters may designate information as confidential, trade secret, or proprietary. 
An agency may not conduct or 
sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number. The OMB control numbers for the EPA’s regulations in 40 CFR are listed in 40 CFR part 9. 
Consistent with the PRA, EPA is 
interested in comments about the accuracy of the burden estimate, and any suggested methods for minimizing respondent burden or improving the automated collection techniques for submitting health and safety data to the Agency. 
C. Regulatory Flexibility Act (RFA) 
I certify that this action will not have 
a significant economic impact on a 
substantial number of small entities under the RFA, 5 U.S.C. 601 et seq. The small entities subject to the requirements of this action are manufacturers of 16 chemicals to be added to the Health and Safety Data Reporting Rule. The Agency has determined that 44 out of 161 of the firms in the affected universe are small entities. Of those small firms, 13 may experience an impact of above 1% and 3 may have impacts above 3%. Details of this analysis are presented in the Economic Analysis of this rule (Ref. 1), which can be found in the docket. 
D. Unfunded Mandates Reform Act 
(UMRA) 
This action does not contain any 
unfunded mandates as described in UMRA, 2 U.S.C. 1531–1538, and does not significantly or uniquely affect small governments. The action imposes no enforceable duty on any state, local or tribal governments or the private sector. 
E. Executive Order 13132: Federalism 
This action does not have federalism 
implications as specified in Executive 
Order 13132 (64 FR 43255, August 10, 1999), because it will not have substantial direct effects on the States, on the relationship between the national government and the States, or on the distribution of power and responsibilities among the various 
levels of government. 
F. Executive Orders 13175: Consultation 
and Coordination With Indian Tribal Governments 
This action does not have tribal 
implications as specified in Executive Order 13175 (65 FR 67249, November 9, 2000) because it will not have substantial direct effects on tribal governments, on the relationship between the Federal government and the Indian tribes, or on the distribution of power and responsibilities between the Federal government and Indian 
tribes. It does not have substantial direct effects on tribal government because this action relates to toxic chemical reporting under EPCRA section 313, which primarily affects private sector facilities. Thus, Executive Order 13175 does not apply to this action. 
G. Executive Order 13045: Protection of 
Children From Environmental Health Risks and Safety Risks 
EPA interprets Executive Order 13045 
(62 FR 19885, April 23, 1997) as applying only to regulatory actions considered significant under section 3(f)(1) of Executive Order 12866 and that concern environmental health or safety risks that EPA has reason to believe may disproportionately affect children, per the definition of ‘‘covered regulatory action’’ in section 2–202 of Executive Order 13045. 
Since this is not a ‘‘covered regulatory 
action,’’ E.O. 13045 does not apply. However, the Policy on Children’s Health does apply. Although this action does not concern an environmental health or safety risk, the information obtained from the reporting required by this rule will be used to inform the Agency’s decision-making process regarding chemical substances to which children may be exposed. This information will also assist the Agency and others in determining whether the chemical substances included in this proposed rule present potential risks, allowing the Agency and others to take appropriate action to investigate and mitigate those risks. 
H. Executive Order 13211: Actions 
Concerning Regulations That Significantly Affect Energy Supply, Distribution, or Use 
This action is not a ‘‘significant 
energy action’’ as defined in Executive Order 13211 (66 FR 28355, May 22, 2001), because it is not likely to have a significant adverse effect on the supply, distribution or use of energy and has not otherwise been designated by the Administrator of the Office of Information and Regulatory Affairs as a 
significant energy action. 
I. National Technology Transfer and 
Advancement Act (NTTAA) 
This rulemaking does not involve any 
technical standards. As such, NTTAA 
section 12(d), 15 U.S.C. 272, does not apply to this action. 
J. Executive Order 12898: Federal 
Actions To Address Environmental Justice in Minority Populations and Low-Income Populations and Executive Order 14096: Revitalizing Our Nation’s Commitment to Environmental Justice for All 
EPA believes that this type of action 
does not directly impact human health 
or environmental conditions. Although this action does not directly impact human health or environmental conditions, EPA identifies and addresses environmental justice concerns in accordance with Executive Orders 12898 (59 FR 7629, February 16, 1994) and 14096 (88 FR 25251, April 26, 2023) by requiring reporting of unpublished health and safety data. This regulatory action requires the submission of unpublished health and safety data for 16 chemical substances that will result in more information being collected and provided to the public. All consumers of products made from these chemicals could benefit from data regarding the chemicals’ health and environmental effects. By requiring reporting of these unpublished studies, EPA provides communities across the U.S. (including communities with environmental justice concerns) with access to these studies. This information can also be used by government agencies and others in determining the potential hazards and risks associated with the listed chemicals. Therefore, the informational benefits of the action will have a positive impact on the human health and environmental impacts on communities with environmental justice 
concerns. 
List of Subjects in 40 CFR Part 716 
Environmental protection, Chemicals, 
Hazardous substances, Reporting and 
recordkeeping requirements. 
Dated: March 20, 2024. 
Michal Freedhoff, 
Assistant Administrator, Office of Chemical 
Safety and Pollution Prevention. 
Therefore, for the reasons stated in the 
preamble, EPA is proposing to amend 
40 CFR chapter I as follows: 
VerDate Sep<11>2014 17:01 Mar 25, 2024 Jkt 262001 PO 00000 Frm 00044 Fmt 4702 Sfmt 4702 E:\FR\FM\26MRP1.SGM 26MRP1ddrumheller on DSK120RN23PROD with PROPOSALS120923 Federal Register / Vol. 89, No. 59 / Tuesday, March 26, 2024 / Proposed Rules 
PART 716—HEALTH AND SAFETY 
DATA REPORTING 
■1. The authority citation for part 716 
continues to read as follows: 
Authority: 15 U.S.C. 2607(d). 
■2. Amend § 716.21 by adding 
paragraph (a)(11) to read as follows: 
§ 716.21 Chemical specific reporting 
requirements. 
(a) * * * 
(11) For 4,4-Methylene bis(2- 
chloraniline) (101–14–4); 4-tert- 
octylphenol(4-(1,1,3,3- Tetramethylbutyl)-phenol) (140–66–9); Acetaldehyde (75–07–7); Acrylonitrile (107–13–1); Benzenamine (62–53–3); Benzene (71–43–2); Bisphenol A (80–5– 7); Ethylbenzene (100–41–4); Naphthalene (91–20–3); Vinyl Chloride (75–01–4); Styrene (100–42–5); Tribomomethane (Bromoform) (75–25– 2); Triglycidyl isocyanurate (2451–62– 9); Hydrogen fluoride (7664–39–3); N- (1,3-Dimethylbutyl)-N′-phenyl-p- phenylenediamine (6PPD) (793–24–8); 
and 2-anilino-5-[(4-methylpentan-2- yl)amino]cyclohexa-2,5-diene-1,4-dione (6PPD-quinone) (2754428–18–5), all 
unpublished studies on health effects (including toxicity studies (in vivo and in vitro) on carcinogenicity, reproductive and developmental effects, genotoxicity, neurotoxicity, immunotoxicity, endocrine effects, and other systemic toxicity); toxicokinetics (absorption, distribution, metabolism, or elimination), including modelling studies, in humans or animals; environmental effects; environmental fate; physical-chemical properties if performed as described in 40 CFR 716.50; and occupational (both users and non-users), general population, consumer, bystander, and environmental exposure must be submitted. Studies showing any measurable content of the substance in the tested substance (single substances or mixture) must be reported. The composition and purity of test substances must be reported if included as part of the study. Studies previously 
submitted to EPA pursuant to a requirement under TSCA or of the submitter’s own accord and studies conducted or to be conducted pursuant to a TSCA section 4 action are exempt 
from the submission of lists of health and safety studies required under 40 CFR 716.35 and the submission of studies required under this rule. 
* * * * * 
■3. Amend § 716.120 by adding 
alphabetically in the table under 
paragraph (d) entries for –‘‘4,4- 
Methylene bis(2-chloraniline);’’ ‘‘4-tert- octylphenol(4-(1,1,3,3- Tetramethylbutyl)-phenol);’’ ‘‘Acetaldehyde;’’ ‘‘Acrylonitrile;’’ ‘‘Benzenamine;’’ ‘‘Benzene;’’ ‘‘Bisphenol A;’’ ‘‘Ethylbenzene;’’ ‘‘Naphthalene;’’ ‘‘Vinyl Chloride;’’ ‘‘Styrene;’’ ‘‘Tribomomethane (Bromoform);’’ ‘‘Triglycidyl isocyanurate;’’ ‘‘Hydrogen fluoride;’’ and ‘‘N-(1,3-Dimethylbutyl)- N′-phenyl-p-phenylenediamine (6PPD);’’ and ’’ 2-anilino-5-[(4- methylpentan-2-yl)amino]cyclohexa- 2,5-diene-1,4-dione (6PPD-quinone)’’ to read as follows: 
§ 716.120 Substance and listed mixtures to 
which this subpart applies. 
(d) * * * 
Category CAS No. Special exemptions Effective date Sunset date 
4,4-Methylene bis(2-chloraniline) ........... 101–14–4 § 716.21(a)(11) applies; § 716.20(a)(9) 
does not apply.[TBD 30 DAYS 
AFTER DATE OF FINAL RULE].[TBD 90 DAYS 
AFTER DATE OF FINAL RULE]. 
4-tert-octylphenol(4-(1,1,3,3- 
Tetramethylbutyl)-phenol).140–66–9 § 716.21(a)(11) applies; § 716.20(a)(9) 
does not apply.[TBD 30 DAYS 
AFTER DATE OF FINAL RULE].[TBD 90 DAYS 
AFTER DATE OF FINAL RULE]. 
Acetaldehyde .......................................... 75–07–0 § 716.21(a)(11) applies; § 716.20(a)(9) 
does not apply.[TBD 30 DAYS 
AFTER DATE OF FINAL RULE].[TBD 90 DAYS 
AFTER DATE OF FINAL RULE]. 
Acrylonitrile ............................................. 107–13–1 § 716.21(a)(11) applies; § 716.20(a)(9) 
does not apply.[TBD 30 DAYS 
AFTER DATE OF FINAL RULE].[TBD 90 DAYS 
AFTER DATE OF FINAL RULE]. 
Benzenamine .......................................... 62–53–3 § 716.21(a)(11) applies; § 716.20(a)(9) 
does not apply applies; § 716.20(a)(9) does not apply.[TBD 30 DAYS 
AFTER DATE OF FINAL RULE].[TBD 90 DAYS 
AFTER DATE OF FINAL RULE]. 
Benzene ................................................. 71–43–2 § 716.21(a)(11) applies; § 716.20(a)(9) 
does not apply.[TBD 30 DAYS 
AFTER DATE OF FINAL RULE].[TBD 90 DAYS 
AFTER DATE OF FINAL RULE]. 
Bisphenol A ............................................ 80–05–7 § 716.21(a)(11) applies; § 716.20(a)(9) 
does not apply.[TBD 30 DAYS 
AFTER DATE OF FINAL RULE].[TBD 90 DAYS 
AFTER DATE OF FINAL RULE]. 
Ethylbenzene .......................................... 100–41–4 § 716.21(a)(11) applies; § 716.20(a)(9) 
does not apply.[TBD 30 DAYS 
AFTER DATE OF FINAL RULE].[TBD 90 DAYS 
AFTER DATE OF FINAL RULE]. 
Naphthalene ........................................... 91–20–3 § 716.21(a)(11) applies; § 716.20(a)(9) 
does not apply.[TBD 30 DAYS 
AFTER DATE OF FINAL RULE].[TBD 90 DAYS 
AFTER DATE OF FINAL RULE]. 
Vinyl Chloride ......................................... 75–01–4 § 716.21(a)(11) applies; § 716.20(a)(9) 
does not apply.[TBD 30 DAYS 
AFTER DATE OF FINAL RULE].[TBD 90 DAYS 
AFTER DATE OF FINAL RULE]. 
Styrene ................................................... 100–42–5 § 716.21(a)(11) applies; § 716.20(a)(9) 
does not apply.[TBD 30 DAYS 
AFTER DATE OF FINAL RULE].[TBD 90 DAYS 
AFTER DATE OF FINAL RULE]. 
Tribomomethane (Bromoform) ............... 75–25–2 § 716.21(a)(11) applies; § 716.20(a)(9) 
does not apply.[TBD 30 DAYS 
AFTER DATE OF FINAL RULE].[TBD 90 DAYS 
AFTER DATE OF FINAL RULE]. 
Triglycidyl isocyanurate .......................... 2451–62–9 § 716.21(a)(11) applies; § 716.20(a)(9) 
does not apply.[TBD 30 DAYS 
AFTER DATE OF FINAL RULE].[TBD 90 DAYS 
AFTER DATE OF FINAL RULE]. 
VerDate Sep<11>2014 17:01 Mar 25, 2024 Jkt 262001 PO 00000 Frm 00045 Fmt 4702 Sfmt 4702 E:\FR\FM\26MRP1.SGM 26MRP1ddrumheller on DSK120RN23PROD with PROPOSALS120924 Federal Register / Vol. 89, No. 59 / Tuesday, March 26, 2024 / Proposed Rules 
Category CAS No. Special exemptions Effective date Sunset date 
Hydrogen fluoride ................................... 7664–39–3 § 716.21(a)(11) applies; § 716.20(a)(9) 
does not apply.[TBD 30 DAYS 
AFTER DATE OF 
FINAL RULE].[TBD 90 DAYS 
AFTER DATE OF FINAL RULE]. 
N-(1,3-Dimethylbutyl)-N′-phenyl-p- 
phenylenediamine (6PPD).793–24–8 § 716.21(a)(11) applies; § 716.20(a)(9) 
does not apply.[TBD 30 DAYS 
AFTER DATE OF FINAL RULE].[TBD 90 DAYS 
AFTER DATE OF FINAL RULE]. 
2-anilino-5-[(4-methylpentan-2-yl) 
amino]cyclohexa-2,5-diene-1,4-dione (6PPD-quinone).2754428–18–5 § 716.21(a)(11) applies; § 716.20(a)(9) 
does not apply.[TBD 30 DAYS 
AFTER DATE OF FINAL RULE].[TBD 90 DAYS 
AFTER DATE OF FINAL RULE]. 
[FR Doc. 2024–06303 Filed 3–25–24; 8:45 am] 
BILLING CODE 6560–50–P 
DEPARTMENT OF DEFENSE 
Defense Acquisition Regulations 
System 
48 CFR Parts 204, 212, 247, and 252 
[Docket DARS–2024–0007] 
RIN 0750–AL12 
Defense Federal Acquisition 
Regulation Supplement: Modification of Notification of Intent To Transport Supplies by Sea (DFARS Case 2020– D026) 
AGENCY : Defense Acquisition 
Regulations System, Department of Defense (DoD). 
ACTION : Proposed rule. 
SUMMARY : DoD is proposing to amend 
the Defense Federal Acquisition Regulation Supplement (DFARS) to remove a DFARS solicitation provision and modify the text of an existing DFARS contract clause to include the operative text of that DFARS provision. 
DATES : Comments on the proposed rule 
should be submitted in writing to the address shown below on or before May 28, 2024, to be considered in the formation of a final rule. 
ADDRESSES : Submit comments 
identified by DFARS Case 2020–D026, using either of the following methods: 
ÆFederal eRulemaking Portal: 
https://www.regulations.gov. Search for 
DFARS Case 2020–D026. Select ‘‘Comment’’ and follow the instructions to submit a comment. Please include ‘‘DFARS Case 2020–D026’’ on any attached document. 
ÆEmail: osd.dfars@mail.mil. Include 
DFARS Case 2020–D026 in the subject line of the message. 
Comments received generally will be 
posted without change to https://www.regulations.gov, including any 
personal information provided. To confirm receipt of your comment(s), please check https://www.regulations.gov, approximately 
two to three days after submission to 
verify posting. 
FOR FURTHER INFORMATION CONTACT : 
David Johnson, telephone 202–913– 5764. 
SUPPLEMENTARY INFORMATION : 
I. Background 
DoD is proposing to revise the DFARS 
to remove the solicitation provision at DFARS 252.247–7022, Representation of Extent of Transportation By Sea, and to revise the contract clause at DFARS 252.247–7023, Transportation of Supplies by Sea, accordingly, to effect the purpose of the provision using only the clause. This change will streamline instructions to contractors regarding required notifications to the Government of transportation of supplies by sea. 
II. Discussion and Analysis 
Currently, DFARS provision 252.247– 
7022 and DFARS clause 252.247–7023 
are included in all solicitations with an 
anticipated value greater than the simplified acquisition threshold, except solicitations for direct purchase of ocean transportation services. The provision requires the offeror to represent whether supplies will or will not be transported by sea in performance of the contract or any subcontract. The clause notifies offerors of their responsibilities when transporting supplies by sea, which include the use of U.S. flag vessels, unless certain situations apply; the submission of a certification with a final invoice; and submission of bills of lading to the contracting officer and to the U.S. Department of Transportation Maritime Administration (MARAD). 
The provision’s notification 
requirement was intended to aid acquisition personnel in carrying out their responsibilities under the clause. By effecting the notification via a solicitation provision, a representation is required from all offerors rather than just the awardee. Given the offeror’s representation has no bearing on its eligibility or selection for award, the notification is better suited to be a requirement in the clause, where only the awardee must notify the contracting officer, as well as MARAD, only if transportation of supplies by sea will occur. Including MARAD on the notification provides all impacted parties with situational awareness and an ability to be proactive in ensuring compliance with the clause requirements. 
Given that DFARS clause 252.247– 
7023 is included in nearly all contracts, and DFARS provision 252.247–7022 is associated with the requirements of 252.247–7023, the text of the clause and provision can be combined. The result reduces the number of provisions required to be used in solicitations and the number of representations offerors must provide, while still maintaining the effect of DFARS provision 252.247– 7022. 
Consequent to removing DFARS 
clause 252.247–7022, this rule removes the clause prescription at DFARS 247.574(a) as well as direction at DFARS 204.1202 and 212.301 relating to the provision. 
III. Applicability to Contracts at or 
Below the Simplified Acquisition Threshold (SAT), for Commercial Products (Including Commercially Available Off-the-Shelf (COTS) Items), and for Commercial Services 
This rule removes the provision at 
DFARS 252.247–7022, along with its prescription at DFARS 247.574(a), and amends the clause at DFARS 252.247– 7032 accordingly to include the substance of the provision. However, this proposed rule does not impose any new requirements on contracts at or below the SAT, for commercial products including COTS items, or for commercial services. The clause will continue to apply to acquisitions at or below the SAT, to acquisitions of commercial products including COTS items, and to acquisitions of commercial services. 
IV. Expected Impact of the Rule 
This change is expected to streamline 
instructions to contractors regarding 
notifications of transportation of supplies by sea. Presently, DFARS 
VerDate Sep<11>2014 17:01 Mar 25, 2024 Jkt 262001 PO 00000 Frm 00046 Fmt 4702 Sfmt 4702 E:\FR\FM\26MRP1.SGM 26MRP1ddrumheller on DSK120RN23PROD with PROPOSALS1